Related references
Note: Only part of the references are listed.Reverse engineering Lewy bodies: how far have we come and how far can we go?
Mohamed Bilal Fares et al.
NATURE REVIEWS NEUROSCIENCE (2021)
Molecular insights into the benefits of nicotine on memory and cognition
Ahmad Alhowail
MOLECULAR MEDICINE REPORTS (2021)
An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors
Omar Alijevic et al.
PHYTOCHEMISTRY (2020)
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
Anne-Laure Mahul-Mellier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Therapeutic Applications of Nicotinic Stimulation: Successes, Failures, and Future Prospects
Paul A. Newhouse
NICOTINE & TOBACCO RESEARCH (2019)
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration
Xinhe Wang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model
Markus Mandler et al.
ALZHEIMERS & DEMENTIA (2019)
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3-acetylcholine nicotinic receptor heteromer
Federica Bono et al.
NEUROBIOLOGY OF DISEASE (2019)
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Ghulam Hussain et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein
Sudhakar R. Subramaniam et al.
NEUROBIOLOGY OF DISEASE (2018)
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents
Nicole K. Polinski et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
Changyoun Kim et al.
MOLECULAR NEURODEGENERATION (2018)
Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors
Mami Noda et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2017)
Systematic evaluation of markers used for the identification of human induced pluripotent stem cells
Sumitha Prameela Bharathan et al.
BIOLOGY OPEN (2017)
Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease
Jay Kardani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies
Anna Villar-Pique et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Neuroinflammation in Synucleinopathies
Somin Lim et al.
BRAIN PATHOLOGY (2016)
Smoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons
Rahul Srinivasan et al.
JOURNAL OF NEUROSCIENCE (2016)
Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease
Mohamed-Bilal Fares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons
J. C. Koch et al.
CELL DEATH & DISEASE (2015)
CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting
Marton Muenz et al.
GENOME MEDICINE (2015)
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
Megha Verma et al.
PLOS ONE (2015)
Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory Neurons
Daniel W. Summers et al.
JOURNAL OF NEUROSCIENCE (2014)
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
Danhui Zhang et al.
MOVEMENT DISORDERS (2014)
Effect of nicotine on L-dopa-induced dyskinesia in animal models of Parkinson's disease: a systematic review and meta-analysis
Cheng-long Xie et al.
NEUROLOGICAL SCIENCES (2014)
Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
David Amschl et al.
BMC NEUROSCIENCE (2013)
Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation
Daniel Paris et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy
Jia-Hong Lu et al.
AUTOPHAGY (2012)
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy
Kiren Ubhi et al.
EXPERIMENTAL NEUROLOGY (2012)
Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease
Abid Oueslati et al.
JOURNAL OF NEUROSCIENCE (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Specification of Midbrain Dopamine Neurons from Primate Pluripotent Stem Cells
Jiajie Xi et al.
STEM CELLS (2012)
Characterizing Human Ion Channels in Induced Pluripotent Stem Cell-Derived Neurons
Alison Haythornthwaite et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Pharmacological Chaperoning of Nicotinic Acetylcholine Receptors Reduces the Endoplasmic Reticulum Stress Response
Rahul Srinivasan et al.
MOLECULAR PHARMACOLOGY (2012)
Acute nicotine enhances strategy-based semantic processing in Parkinson's disease
Anna D. Holmes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Nicotine up-regulates alpha 4 beta 2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning
Rahul Srinivasan et al.
JOURNAL OF GENERAL PHYSIOLOGY (2011)
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Sonja Kriks et al.
NATURE (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
Luping Z. Huang et al.
NEUROPHARMACOLOGY (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
α6β2*and α4β2*Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Maryka Quik et al.
PHARMACOLOGICAL REVIEWS (2011)
Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors
Wenlin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
被撤回的出版物: Efficient Derivation of Functional Floor Plate Tissue from Human Embryonic Stem Cells (Retracted article. See vol. 30, pg. 905, 2023)
Christopher A. Fasano et al.
CELL STEM CELL (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Kiren Ubhi et al.
JOURNAL OF NEUROSCIENCE (2010)
α6β2*and α4β2*Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease
Xiomara A. Perez et al.
MOLECULAR PHARMACOLOGY (2010)
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Dong-Pyo Hong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses
Eran Nizri et al.
JOURNAL OF IMMUNOLOGY (2009)
Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
Cassia R. Overk et al.
NEUROBIOLOGY OF DISEASE (2009)
Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study
Emmanuel Itti et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Nicotine and Parkinson's disease: Implications for therapy
Maryka Quik et al.
MOVEMENT DISORDERS (2008)
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells
Karen Riveles et al.
NEUROTOXICOLOGY (2008)
Chronic high dose transdermal nicotine in Parkinson's disease: an open trial
G. Villafane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age
Raja Kittappa et al.
PLOS BIOLOGY (2007)
Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells
Yuichi Ono et al.
DEVELOPMENT (2007)
Pooled analysis of tobacco use and risk of Parkinson disease
Beate Ritz et al.
ARCHIVES OF NEUROLOGY (2007)
Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action
Hyun Jung Park et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases
Kenjiro Ono et al.
EXPERIMENTAL NEUROLOGY (2007)
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates
Maryka Quik et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Nicotine, but neither the α4β2 ligand RJR2403 nor an α7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle
N. P. Visanji et al.
NEUROPHARMACOLOGY (2006)
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin
P Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease
S Lemay et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin
K Parain et al.
BRAIN RESEARCH (2003)
Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats
CK Meshul et al.
EXPERIMENTAL NEUROLOGY (2002)
Transdermal nicotine in PD - A randomized, double-blind, placebo-controlled study
A Vieregge et al.
NEUROLOGY (2001)
Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice
RE Ryan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra
G Costa et al.
BRAIN RESEARCH (2001)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Nicotinic receptors and Parkinson's disease
M Quik et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
